Keyphrases
Tumor Necrosis Factor-α
100%
Vascular Effects
100%
Type 2 Diabetic Patients
100%
Obese Patients
100%
Etanercept
100%
Serotonin
100%
Metabolic Effects
100%
β-cell Function
66%
Metabolic
66%
Interleukin-6
66%
Sodium Nitroprusside
66%
Insulin Sensitivity
66%
C-reactive Protein
66%
Glucose Uptake
66%
Insulin
66%
Whole-body Insulin Sensitivity
33%
Whole-body
33%
Hyperinsulinemic-euglycemic Clamp
33%
Vasodilatation
33%
Beneficial Effects
33%
Forearm
33%
Endothelium
33%
Insulin Resistance
33%
Systemic Inflammation Response Index
33%
Twice Daily
33%
Endothelial Dysfunction
33%
Intra-arterial Infusion
33%
Forearm Blood Flow
33%
Plasma Parameters
33%
Intravenous Glucose Tolerance Test
33%
Inflammatory Cytokines
33%
Blood Glucose
33%
Insulin Action
33%
Vasodilator Responses
33%
Medicine and Dentistry
Patient with Type 2 Diabetes
100%
Tumor Necrosis Factor
100%
Serotonin
60%
Insulin Sensitivity
40%
C Reactive Protein
40%
Cell Function
40%
Glucose Uptake
40%
Interleukin 6
40%
Beta Cell
40%
Sodium Nitroprusside
40%
Infusion
20%
Intravenous Glucose Tolerance Test
20%
Endothelial Dysfunction
20%
Inflammatory Cytokine
20%
Insulin Resistance
20%
Blood Glucose
20%
Vasodilatation
20%
Forearm Blood Flow
20%
Intraarterial Drug Administration
20%
Pharmacology, Toxicology and Pharmaceutical Science
Etanercept
100%
Tumor Necrosis Factor
100%
Non Insulin Dependent Diabetes Mellitus
100%
Serotonin
60%
C Reactive Protein
40%
Interleukin 6
40%
Nitroprusside Sodium
40%
Endothelial Dysfunction
20%
Insulin Resistance
20%
Cytokine
20%
Nursing and Health Professions
Etanercept
100%
Serotonin
60%
Forearm Blood Flow
20%
Endothelial Dysfunction
20%